| Date | Title | Description |
| 02.07.2025 | OncoZenge resolves on a directed share issue to Sichuan Yangtian Bio-Pharmaceutical, after completion of the ODI process | OncoZenge resolves on a directed share issue to Sichuan Yangtian Bio-Pharmaceutical, after completion of the ODI process
Wed, Jul 02, 2025 08:55 CET Report this content
The information contained in this press release is not for publication,... |
| 21.05.2025 | Cinis Fertilizer's Rights Issue: A Green Light for Growth | Cinis Fertilizer AB is stepping into the spotlight. The Swedish green-tech company is on the verge of a significant financial maneuver: a rights issue. This move, approved by shareholders at an Extraordinary General Meeting, aims to raise c... |
| 19.05.2025 | Cinis Fertilizer publishes information document regarding the rights issue | Cinis Fertilizer publishes information document regarding the rights issue
Mon, May 19, 2025 15:10 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STAT... |
| 28.04.2025 | Last day of the subscription period in Diamyd Medicals rights issue | Last day of the subscription period in Diamyd Medicals rights issue
Mon, Apr 28, 2025 12:10 CET Report this content
Tomorrow, Tuesday, April 29, 2025, is the last day to subscribe for participation in Diamyd Medical AB’s (publ) ("Diamy... |
| 23.04.2025 | Navigating the Financial Landscape: Recent Developments in Diamyd Medical and JY Holding | In the world of finance, every decision is a ripple in a vast ocean. Two companies, Diamyd Medical and JY Holding, are making waves with their recent activities. Both are navigating the currents of investment and growth, each with its uniqu... |
| 22.04.2025 | Shareholders in Diamyd Medical, including the Chairman of the Board, have provided additional subscription commitments in the ongoing rights issue | Shareholders in Diamyd Medical, including the Chairman of the Board, have provided additional subscription commitments in the ongoing rights issue
Tue, Apr 22, 2025 14:05 CET Report this content
Chairman of the Board, Anders Essen-Möller, i... |
| 15.04.2025 | Diamyd Medical: Pioneering a New Era in Autoimmune Diabetes Treatment | Diamyd Medical is at the forefront of a medical revolution. The company is making strides in the treatment of Type 1 Diabetes and Latent Autoimmune Diabetes in Adults (LADA). Their recent quarterly report highlights significant progress and... |
| 14.04.2025 | Diamyd Medical publishes prospectus with regards to the rights issue | Diamyd Medical publishes prospectus with regards to the rights issue
Mon, Apr 14, 2025 13:10 CET Report this content
THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLICATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, C... |
| 21.03.2025 | Diamyd Medical announces additional subscription commitments for upcoming rights issue | Diamyd Medical announces additional subscription commitments for upcoming rights issue
Fri, Mar 21, 2025 12:10 CET Report this content
An investor consortium led by Patrik Hansen has submitted subscription commitments totaling SEK 21.0 mill... |
| 17.03.2025 | Exercise Period for Warrants TO6 in Dicot Pharma Begins Today | Exercise Period for Warrants TO6 in Dicot Pharma Begins Today
Mon, Mar 17, 2025 08:15 CET Report this content
Uppsala, Sweden, March 17, 2025. The exercise period for the warrants of series TO6, which were issued in connection with Dicot Ph... |
| 13.03.2025 | Navigating the Financial Waters: Recent Developments in Diamyd Medical and Dicot Pharma | In the world of biotechnology, the tides can shift rapidly. Companies like Diamyd Medical and Dicot Pharma are navigating these waters with strategic moves aimed at securing their futures. Recent announcements from both firms reveal their i... |
| 11.03.2025 | Subscription Price SEK 0.38 for Warrants TO 6 in Dicot Pharma Determined; corresponding to SEK 0.19 per share | Subscription Price SEK 0.38 for Warrants TO 6 in Dicot Pharma Determined; corresponding to SEK 0.19 per share
Tue, Mar 11, 2025 08:30 CET Report this content
Uppsala, Sweden, March 11, 2025. Dicot Pharma carried out a rights issue of units ... |
| 10.03.2025 | Diamyd Medical announces additional subscription commitments for upcoming rights issue | Diamyd Medical announces additional subscription commitments for upcoming rights issue
Mon, Mar 10, 2025 08:45 CET Report this content
THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLICATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUS... |
| 18.02.2025 | Diagonal Bio AB resolves on a directed issue of units to all external underwriters | Diagonal Bio AB resolves on a directed issue of units to all external underwriters
Tue, Feb 18, 2025 14:30 CET Report this content Read original
The Board of Directors of Diagonal Bio AB ("Diagonal Bio" or the "Company")... |
| 23.01.2025 | Monivent confirms that the communicated rights issue is 100% secured | Monivent confirms that the communicated rights issue is 100% secured
Thu, Jan 23, 2025 14:45 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AU... |
| 22.01.2025 | Eevia Health Plc: Navigating Financial Waters with a New Rights Issue | Eevia Health Plc is charting a new course. The company has announced a rights issue aimed at raising approximately SEK 12.1 million. This move comes on the heels of a strategic reorientation initiated in late 2024. The goal? To stabilize th... |
| 17.01.2025 | The Board of Directors of Eevia Health Plc has today resolved on a rights issue of approximately SEK 12.1 million, for which the intention was announced on 30 December 2024 | The Board of Directors of Eevia Health Plc has today resolved on a rights issue of approximately SEK 12.1 million, for which the intention was announced on 30 December 2024
Fri, Jan 17, 2025 15:06 CET Report this content
THE INFORMATION CON... |
| 24.11.2024 | Peptonic and DUG Foodtech: Navigating Financial Waters in Sweden's Biotech and Food Sectors | In the ever-evolving landscape of Swedish business, two companies stand out: Peptonic Medical AB and DUG Foodtech AB. Both are making waves in their respective fields—biomedical and food technology. Their recent financial maneuvers reveal m... |
| 22.11.2024 | DUG Foodtechs rights issue is registered – conversion of BTA into shares | DUG Foodtechs rights issue is registered – conversion of BTA into shares
Fri, Nov 22, 2024 15:00 CET Report this content
22 November, 2024, Lund, Sweden
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UN... |
| 18.11.2024 | Today is the last day of trading with subscription rights in Flat’s rights issue of 80 MSEK, and the subscription period ends on November 21 | Today, November 18, 2024, is the last day of trading in subscription rights in the ongoing rights issue of SEK 80 million in Flat Capital AB (publ) (“Flat” or the “Company”). The subscription period ends on November 21, 2024. A teaser, pros... |
| 10.11.2024 | Navigating the Financial Seas: Recent Developments in Swedish Biotech and Foodtech | In the world of finance, timing is everything. Recent announcements from two Swedish companies, Peptonic Medical AB and DUG Foodtech AB, illustrate the dynamic nature of capital markets. Both companies are charting their courses through rig... |
| 06.11.2024 | DUG Foodtech announces the outcome of the rights issue | DUG Foodtech announces the outcome of the rights issue
Wed, Nov 06, 2024 06:25 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN,... |
| 31.10.2024 | Flat publishes prospectus regarding the rights issue of 80 MSEK | Summary
Publication of the Prospectus
The Prospectus which has been prepared in connection with the Rights issue has today been approved and registered by the Swedish Financial Supervisory Authority and is available on the Flat's website (f... |
| 30.10.2024 | Last day of trading in subscription rights in DUG Foodtech’s Rights Issue of shares | Last day of trading in subscription rights in DUG Foodtech’s Rights Issue of shares
Wed, Oct 30, 2024 08:00 CET Report this content
Today, 30 October 2024, is the last day of trading in the subscription rights issued in connection with DUG ... |
| 25.10.2024 | Elicera Therapeutics and DUG Foodtech: A Dual Dive into Innovation and Investment | In the ever-evolving landscape of biotechnology and food technology, two companies stand out: Elicera Therapeutics and DUG Foodtech. Each is navigating its own path, yet both share a common goal: to innovate and thrive in their respective f... |
| 25.10.2024 | Navigating the Financial Waters: Insights from Recent Corporate Reports | In the world of finance, numbers tell stories. They reveal the pulse of a company, its challenges, and its triumphs. Two recent reports from ADDvise Group and DUG Foodtech provide a glimpse into the current landscape of corporate finance. E... |
| 21.10.2024 | Publication of information memorandum – the subscription period of DUG Foodtech’s Rights Issue of shares commences today | Publication of information memorandum – the subscription period of DUG Foodtech’s Rights Issue of shares commences today
Mon, Oct 21, 2024 08:30 CET Report this content
Today, 21 October 2024, DUG Foodtech AB (publ) ("DUG Foodtech"... |
| 03.10.2024 | Tradedoubler's Rights Issue: A Financial Success Story | Tradedoubler AB has made waves in the financial markets with its recent rights issue. The company, a stalwart in digital marketing, has successfully navigated the turbulent waters of capital raising. The outcome? A resounding oversubscripti... |
| 26.09.2024 | Tradedoubler's rights issue oversubscribed according to preliminary outcome | Tradedoubler's rights issue oversubscribed according to preliminary outcome
Thu, Sep 26, 2024 18:50 CET Report this content
The information in this press release is not intended for distribution, publication or public release, directly or i... |
| 25.09.2024 | The last day of trading in Diamyd Medical's warrants of series TO 3 is today | The last day of trading in Diamyd Medical's warrants of series TO 3 is today
Wed, Sep 25, 2024 08:15 CET Report this content
Today, Wednesday, September 25, 2024, is the last day of trading in Diamyd Medical AB’s (publ) (“Diamyd Medical” or... |
| 12.09.2024 | DUG Foodtech AB: Navigating Financial Waters with a Rights Issue | DUG Foodtech AB, a rising star in the plant-based food sector, is gearing up for a significant financial maneuver. The company has announced a fully guaranteed rights issue aimed at raising approximately SEK 28 million. This move comes on t... |
| 11.09.2024 | The Board of Directors of DUG Foodtech AB (publ) resolves on a fully guaranteed rights issue of shares of approximately SEK 28 million and raises bridge loans of approximately SEK 3 million | The Board of Directors of DUG Foodtech AB (publ) resolves on a fully guaranteed rights issue of shares of approximately SEK 28 million and raises bridge loans of approximately SEK 3 million
Wed, Sep 11, 2024 19:30 CET Report this content
NO... |
| 09.09.2024 | Tradedoubler publishes prospectus | Tradedoubler publishes prospectus
Mon, Sep 09, 2024 16:00 CET Report this content
The prospectus relating to Tradedoubler AB’s (publ) (“Tradedoubler”) rights issue of approximately SEK 50.5 has been approved and registered by the Swedish Fi... |
| 04.09.2024 | G2 Acquisition Inc. Makes Bold Move to Acquire ZignSec AB: A Strategic Gamble in Risk Solutions | In a significant development in the financial technology sector, G2 Acquisition Inc. (G2RS) has announced a recommended cash offer to acquire ZignSec AB (publ), a company specializing in risk and compliance services. This strategic move aim... |
| 04.09.2024 | G2 Acquisition Inc. publishes the offer document for the recommended public offer to the shareholders of ZignSec AB (publ) | G2 Acquisition Inc. publishes the offer document for the recommended public offer to the shareholders of ZignSec AB (publ)
Wed, Sep 04, 2024 08:15 CET Report this content
The Offer is not being made, and this press release may not be distri... |
| 02.09.2024 | The exercise period for Diamyd Medical's warrants of series TO 3 begins today | The exercise period for Diamyd Medical's warrants of series TO 3 begins today
Mon, Sep 02, 2024 11:10 CET Report this content
In 2023, Diamyd Medical AB (publ) (”Diamyd Medical” or the ”Company”) issued a total of 9,165,682 warrants of seri... |
| 26.08.2024 | Dicot informs about last day for subscription of units in ongoing rights issue | Dicot informs about last day for subscription of units in ongoing rights issue
Mon, Aug 26, 2024 08:45 CET Report this content
Uppsala, Sweden, August 26, 2024. Friday August 30, 2024, is the last day for subscription in Dicot Pharma's ongo... |
| 16.08.2024 | The subscription period in Dicot Pharma's rights issue begins today | The subscription period in Dicot Pharma's rights issue begins today
Fri, Aug 16, 2024 08:20 CET Report this content
Uppsala, Sweden, August 16, 2024. The subscription period in Dicot Pharma AB's rights issue of units consisting of shares an... |
| 14.08.2024 | Dicot Pharma AB publishes prospectus in connection with the upcoming rights issue | Dicot Pharma AB publishes prospectus in connection with the upcoming rights issue
Wed, Aug 14, 2024 15:34 CET Report this content
Uppsala, Sweden, August 14, 2024. The Board of Directors of Dicot Pharma AB today publishes an EU growth prosp... |
| 20.06.2024 | Jumpgate AB announces the last day for trading with paid subscribed shares (BTA) | Jumpgate AB announces the last day for trading with paid subscribed shares (BTA)
Thu, Jun 20, 2024 15:20 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRAL... |
| 12.06.2024 | Jumpgate AB announces outcome of the rights issue and decides on a directed share issue to guarantors | Jumpgate AB announces outcome of the rights issue and decides on a directed share issue to guarantors
Wed, Jun 12, 2024 13:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTL... |
| 31.05.2024 | Reminder: Last day to subscribe in Jumpgate AB’s ongoing rights issue | Reminder: Last day to subscribe in Jumpgate AB’s ongoing rights issue
Fri, May 31, 2024 09:40 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KO... |
| 09.05.2024 | Jumpgate AB resolves to carry out a rights issue of ca 28.6 MSEK, fully covered by subscription commitments, subscription intents and guarantee commitments | Jumpgate AB resolves to carry out a rights issue of ca 28.6 MSEK, fully covered by subscription commitments, subscription intents and guarantee commitments
Thu, May 09, 2024 19:30 CET Report this content
and proposes a directed conversion i... |
| 28.03.2024 | Diamyd Medical publishes prospectus with regards to the rights issue | Diamyd Medical publishes prospectus with regards to the rights issue
Thu, Mar 28, 2024 11:30 CET Report this content
THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLICATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, C... |
| 27.03.2024 | Late Acceptance of Public Offer until 12.00 Today | Late Acceptance of Public Offer until 12.00 Today
Wed, Mar 27, 2024 08:30 CET Report this content
Ayima has been informed that Avanza and other trading platforms may have closed access to the offer through their interface earlier than the o... |
| 16.10.2023 | Diamyd Medical publishes prospectus with regards to the rights issue | Diamyd Medical publishes prospectus with regards to the rights issue
Mon, Oct 16, 2023 09:30 CET Report this content
THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLICATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, C... |
| 08.08.2023 | Flat Capital publishes prospectus in connection with a rights issue of approximately SEK 138 million | The Board of Directors of Flat Capital AB (publ) (“Flat” or the “Company”) has, in connection with the rights issue of approximately SEK 138 million (the “Rights issue”) announced on July 19, 2023, prepared an EU Growth Prospectus, which ha... |
| 26.07.2023 | Nitro Games Oyj: Nitro Games publishes supplement to prospectus regarding the ongoing rights issue | Nitro Games Oyj: Nitro Games publishes supplement to prospectus regarding the ongoing rights issue
Wed, Jul 26, 2023 10:30 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED S... |
| 05.07.2023 | Nitro Games publishes EU growth prospectus in connection with its EUR 6.6 million rights issue | Nitro Games publishes EU growth prospectus in connection with its EUR 6.6 million rights issue
Wed, Jul 05, 2023 10:30 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATE... |
| 13.06.2023 | Nitro Games plans to arrange a rights issue of approximately SEK 77.4 million and secures bridge financing | Nitro Games plans to arrange a rights issue of approximately SEK 77.4 million and secures bridge financing
Tue, Jun 13, 2023 08:30 CET Report this content
The Board of Directors of Nitro Games Oyj (“Nitro Games” or the “Company”) has today ... |
| 24.05.2023 | Diamyd Medical resolves on a rights issue of shares of approximately SEK 163 million and convenes an EGM to resolve on an issue of warrants and amendment of the articles of association | Diamyd Medical resolves on a rights issue of shares of approximately SEK 163 million and convenes an EGM to resolve on an issue of warrants and amendment of the articles of association
Wed, May 24, 2023 08:55 CET Report this content
THIS PR... |
| 17.03.2023 | The subscription price for exercise of warrants series TO3 has been determined to SEK 2.44 and the exercise period begins on Monday 20 March 2023 | The subscription price for exercise of warrants series TO3 has been determined to SEK 2.44 and the exercise period begins on Monday 20 March 2023
Fri, Mar 17, 2023 19:00 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, ... |
| 15.12.2022 | Publication of supplementary prospectus regarding Eurobattery Minerals rights issue | Publication of supplementary prospectus regarding Eurobattery Minerals rights issue
Thu, Dec 15, 2022 16:50 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALI... |
| 05.12.2022 | Eurobattery Minerals publishes prospectus and invites to investor meeting | Eurobattery Minerals publishes prospectus and invites to investor meeting
Mon, Dec 05, 2022 14:45 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA,... |
| 16.12.2021 | Three major shareholders announce that their entire holding of warrants of series 2021 in InCoax Networks AB (publ.) will be submitted for redemption | Three major shareholders announce that their entire holding of warrants of series 2021 in InCoax Networks AB (publ.) will be submitted for redemption Thu, Dec 16, 2021 08:30 CET
The company's largest shareholders Saugatuck Invest, Norrlands... |
| 01.12.2021 | The exercise period for warrants of series 2021 in InCoax begins today, Wednesday, December 1, 2021 | The exercise period for warrants of series 2021 in InCoax begins today, Wednesday, December 1, 2021 Wed, Dec 01, 2021 08:30 CET
In April 2021, InCoax Networks AB (publ) (“InCoax” or the “Company”) carried out a rights issue of units, includ... |
| 04.10.2021 | Savosolar Oyj : publishes EU growth prospectus in connection to its EUR 6.1 million rights issue | Savosolar Plc
Company Announcement 4 October 2021 at 12.15 p.m. (CEST)
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH ... |
| 25.05.2020 | SAVOSOLAR OYJ
Savosolar Oyj : publishes prospectus for EUR 4.3 million rights issue | Savosolar Plc
Company Announcement, Insider information 25 May 2020 at 11.15 a.m. (CEST)
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, S... |
